The current emerging coronavirus outbreak in Wuhan demonstrates that we need drugs for emerging viruses and especially for emerging coronaviruses. Below, we tell the story behind our recent paper on a broad-spectrum antiviral which may be able to fill this very important public health need.
Deadly coronaviruses have emerged recently and no vaccines or therapeutics are available to combat them. To understand how these viruses attach to and enter our cells, we determined the structure of the molecule initiating infection in complex with various sialic acid derivatives.
Register to Nature Portfolio Microbiology Community
The Nature Portfolio Microbiology Community provides a forum for the sharing and discussion of ideas and opinions about microbiology. Through posts, discussion, image and video content, the community space can be used by members to communicate with each other, and with editors, about topics ranging from the science itself through to policy, society and day to day life. It is also a place to learn more about the activities of Nature Microbiology's editors and the policies and practices of the journal.